Human corneal transplantation (keratoplasty) is typically considered to have superior short-
and long-term outcomes and lower requirement for immunosuppression compared to solid …

Macrophages have emerged at the forefront of research in immunology and transplantation
because of recent advances in basic science. New findings have illuminated macrophage …

There is an unmet clinical need for immunotherapeutic strategies that specifically target the
active immune cells participating in the process of rejection after solid organ transplantation …

Organ transplantation is a life‐saving strategy for patients with end‐stage organ failure. Over
the past few decades, organ transplantation has achieved an excellent success in short …

Organ transplantation remains to be a treatment of choice for patients suffering from
irreversible organ failure. Immunosuppressive (IS) drugs employed to maintain the allograft …

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of
immunosuppressive cells of the myeloid lineage upregulated by mediators of inflammation …

Immune tolerance to allografts has been pursued for decades as an important goal in
transplantation. Administration of apoptotic donor splenocytes effectively induces antigen …

Myeloid-derived suppressor cells (MDSC) are defined as a group of myeloid cells with
potent immunoregulatory functions that have been shown to be involved in a variety of …

Cell membrane engineering, including live cell membrane bioconjugation and cell
membrane-derived nanomaterials is a highly promising strategy to modulate immune …

Age impacts alloimmunity. Effects of aging on T‐cell metabolism and the potential to
interfere with immunosuppressants have not been explored yet. Here, we dissected …